AIG
GBIO

American International Group’s Generation Bio GBIO Stock Holding History

American International Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,232
Closed -$90.8K – 1053
2024
Q1 		$90.8K Sell
2,232
-19
-0.8% -$447 ﹤0.01% 2570
2023
Q4 		$37.1K Sell
2,251
-9
-0.4% -$157 ﹤0.01% 2872
2023
Q3 		$85.7K Buy
2,260
+80
+4% +$3.79K ﹤0.01% 2589
2023
Q2 		$120K Sell
2,180
-141
-6% -$6.47K ﹤0.01% 2464
2023
Q1 		$99.8K Buy
2,321
+46
+2% +$2.23K ﹤0.01% 2454
2022
Q4 		$89.4K Sell
2,275
-8
-0.4% -$420 ﹤0.01% 2565
2022
Q3 		$121K Buy
2,283
+105
+5% +$6.57K ﹤0.01% 2447
2022
Q2 		$143K Buy
2,178
+3
+0.1% +$196 ﹤0.01% 2384
2022
Q1 		$160K Sell
2,175
-154
-7% -$8.92K ﹤0.01% 2377
2021
Q4 		$165K Sell
2,329
-69
-3% -$12K ﹤0.01% 2470
2021
Q3 		$601K Sell
2,398
-57
-2% -$13.6K ﹤0.01% 1734
2021
Q2 		$660 Buy
2,455
+107
+5% +$32K ﹤0.01% 1762
2021
Q1 		$668 Buy
2,348
+1,634
+229% +$523K ﹤0.01% 1680
2020
Q4 		$202 Sell
714
-20
-3% -$6.42K ﹤0.01% 2284
2020
Q3 		$227K Buy
+734
New +$175K ﹤0.01% 2067

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American International Group's GBIO Position: Q2 2024 in Review

American International Group sold out of Generation Bio (GBIO) in Q2 2024, closing a stake of 2,232 shares — an estimated $90.8K sold.

American International Group first reported a position in GBIO in Q3 2020 and held it in 15 quarters. The position peaked at $601K in Q3 2021. 77 funds tracked by Wall St. Rank hold GBIO as of Q2 2024.

  • American International Group reported no remaining Generation Bio position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 2,232 Generation Bio shares in Q2 2024, an estimated $90.8K.
  • American International Group first reported a position in Generation Bio in Q3 2020 and held it in 15 quarters.
  • American International Group's Generation Bio position peaked at $601K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Generation Bio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.